drugset / Trial / NCT01650584

Evaluation of Ocular Comfort With ISTA Tears vs Systane

NCT01650584

Completed 35 enrolled Bausch & Lomb Incorporated
Non-randomizedSingle-groupOpen-labelTreatment

Summary

To assess the comfort preference of ISTA Tears vs Systane in patients with dry eye disease (DED)

Timeline

Start
2012-06
Primary completion
2012-12
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Subject ISTA Tears Unknown
Comparator Systane Other / unclassified

Indications